Skip to main content
. 2024 Jan 30;41(3):481–491. doi: 10.1007/s11095-024-03661-x

Table III.

Mean (± SD) and median (range) time parameters estimates using the graphical and modeling approaches for Class I/III and Class II/IV drugs listed in Table II

Model Temporal parameter Class I/III Class II/IV
Graphical τd (h)

0.28 (± 0.4)[mean]

0.33 (0.086–1.86)[median]

-
M.D.T. (h)

0.13 (± 0.06)[mean]

0.109 (0.050–0.373)[median]

-
M.D.T.s. (h) -

2.3 (± 7) [mean]

0.32 (0.027–30) [median]

Noyes-Whitney τd (h)

0.35 (± 0.2)[mean]

0.29 (0.084–0.97)[median]

-
M.D.T. (h)

0.098 (± 0.05)[mean]

0.083 (0.026–0.24)[median]

-
M.D.T.s. (h) -

2.7 (± 6) [mean]

0.42 (0.018–24) [median]

Weibull τd (h)

0.33 (± 0.16)[mean]

0.29 (0.084–0.88)[median]

-
M.D.T. (h)

0.11 (± 0.05)[mean]

0.106 (0.031–0.21)[median]

-
M.D.T.s. (h) -

0.27 (± 0.2) [mean]

0.25 (0.018–0.74)[median]

Reaction-limited τd (h) - -
M.D.T. (h)

0.07917 (± 0.00882) [mean]

0.08093 (0.05143–0.10293) [median]

-
M.D.T.s. (h) -

0.46 (± 0.7)[mean]

0.29 (0.034–3.2)[median]